Podcasts about Allergan

A recent episode of The Skinny Confidential (a great podcast!), TheOrganicBunny made some bold claims about Botox's history, uses, and toxicity that don't line up with the facts. Don't get me wrong - EVERYONE can have an opinion on Botox and it's application. However, Botox is the most studied drug ever and the scientific studies suggest that TheOrganicBunny missed the mark.The Skinny Confidential Episode w/ TheOrganicBunny: https://open.spotify.com/episode/4GrYjRIzHfKAu7IxXchR6k?si=2b83b9522efa4abaTimestamps00:00 Intro02:52 Recent Learning Experience03:49 What is Botox?05:39 Salmon Sperm07:12 Injecting Botox - What's it Doing?08:55 Botox Clinical Trials10:55 Botox Dosing13:44 Common Side Effects16:53 Finding REAL Botox18:28 Botox Crosses the Blood-Brain Barrier / Was Used in War19:45 Exploratory Studies20:27 What is the Mental Impact of Elevated Confidence?22:14 My Botox History SummarizedDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Sculptra, one of the most popular biomodulators on the market, is a vital part of my facial balancing toolkit. As I like to put it, the "cake" we build with your face has Sculptra as a foundation. Filler is like the frosting and is used as needed. Stick around for the whole episode as I break down the history, make-up, use cases, costs, and areas of treatment!Timestamps00:00 Intro01:17 What is Sculptra?03:50 Galderma Purchases Sculptra05:17 Nodules from Sculptra06:47 PLLA - Poly-L-Lactic Acid08:36 Beet Sugar Component09:12 How Sculptra is Injected10:05 How Much Sculptra Do I Need?13:51 "Building the Cake" With Sculptra and Filler14:54 Before & After: Sculptra/Filler15:24 Cost of Sculptra 16:28 Sculptra Placement17:25 RecapDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Let's keep it real today - some people want you to think that anything is possible in aesthetics. While more and more is possible every year, we still have to face the truth about the treatments we do... Pill 1: The Lips Have Limits Pill 2: Bruising Happens Pill 3: Facial Asymmetry is Normal Pill 4: It's Normal For Lines to Come Back (Botox)Products Mentioned In This Episode:Zinc Supplement - https://perfectdoserx.com/products/reacted-zincTimestamps00:00 Intro01:15 Pill 1: The Lips Have Limits02:09 Have Your Lips Hit Their Limit?04:13 How You Should Pace Your Lip Filler05:46 Pill 2: Bruising Happens06:47 How to REDUCE Bruising (Not Prevent)07:47 Pill 3: Facial Symmetry09:54 Pill 4: It's Normal For Lines to Come Back (Botox)13:01 Make Your Botox Last Longer15:03 RecapDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this episode, Dr. Kristen Herzog demystifies PRP (Platelet-Rich Plasma), PRF (Platelet-Rich Fibrin), EZ Gel, and PDGF (Platelet-Derived Growth Factors) - explaining the pros and cons of each treatment. You will learn about the history of the treatments and where the ideal injection sites are. The star of this episode is PDGF, as it's been shown to be multiples above your natural growth factor concentration and thus much more effective than traditional PRP/PRF. However, if you're looking to get your lips injected, Dr. Herzog still believes that traditional filler is the way to go. Timestamps00:00 Intro01:05 Life Update03:04 Biostimulators are Trending Up04:31 PRP - Platelet-Rich Plasma06:35 PRF - Platelet-Rich Fibrin07:53 EZ Gel09:31 Comparing EZ Gel, PRP, and PRF10:01 Injecting - Which Ones for What?10:38 "Can You Put EZ Gel in the Lips?"12:32 Choosing Fillers14:16 EZ Gel Challenges15:29 Undereye Filler16:28 PDGF - Platelet-Derived Growth Factors18:25 THIS Is Why PDGF Is Best20:04 The Current Uses of PDGF21:08 "Off-Label" Treatments?22:16 TakeawaysDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Ever felt stuck with an injury that won't heal? Whether it's a sprained ankle, chronic pain, or post-surgery recovery, what if you could speed up the healing process—naturally?In this episode, I sit down with Dr. Jo, a former aerospace engineer turned homeopathy expert, who shares her jaw-dropping journey from satellites to sprains. She reveals how a desperate search for her daughter's healing led her to discover the power of homeopathy—and eventually create ActiveMend, a game-changing product that accelerates the body's ability to heal itself.We dive into real-life stories, including a pro athlete who went from nearly quitting to a career breakthrough, and the science behind why Arnica and homeopathy work. If you've ever dealt with an injury, know someone in pain, or simply want to understand how to optimize your body's natural healing powers, this episode is a must-listen!Tune in now to learn how you can recover faster, move better, and get back to the things you love—without relying on pharmaceuticals.Chapter:[00:00] Episode's Preview[00:49] Podcast Introduction[01:33] Topic and Guest Introduction[03:30] Meet Dr. Jo: From Aerospace Engineer to Homeopathy Expert[07:19] ActivMend: A Breakthrough in Natural Healing[11:30] Why ActivMend Works Better Than Traditional Arnica[13:49] Does Homeopathy Work for Everyone?[15:51] Stigma Around Homeopathy[18:41] God's Design for Healing[19:44] Why Some Injuries Never Heal & How to Fix It[24:50] A Pro Tennis Player's Miraculous Recovery[29:18] Faster Recovery After Surgery: A Plastic Surgeon's Study[31:42] Dr. Jo's Personal Life: Tennis, Dance, & Fun[33:24] Final Thoughts & How to Get ActivMend and My FreebieResources mentioned:ActivMend WebsiteFREE VISIBLY FIT™ in 7 DAYS Workout & Meal PlanVisibly Fit 7-Week Accelerator ProgramConnect with today's guest:Dr. Jo Polich was thriving in her engineering career, leading major projects at IBM and Alcatel, until life threw her a curveball—her young daughter fell seriously ill. Despite visiting countless specialists, no one could find a solution. Out of sheer desperation, Dr. Jo turned to a natural remedy. To her amazement, her daughter's digestive issues disappeared for the first time in a year.Driven by curiosity and hope, Dr. Jo dove into researching natural treatments and their effectiveness. Inspired by her daughter's recovery, she made a bold move—leaving her role as Director of Engineering to pursue a medical degree and open her own practice. She dedicated herself to understanding the science behind natural healing, blending her engineering mindset with medical expertise.Her first breakthrough, a high-potency hydrogel called OcuMend, quickly gained the trust of top dermatologists for its ability to dramatically reduce bruising and pain. Their success stories were so compelling that pharmaceutical giant Allergan licensed the technology—the first time a major company embraced an arnica-based product.Now, Dr. Jo has taken her innovation even further with ActivMend, a powerful formula designed to help athletes and active individuals recover faster from injuries. Whether you're getting back on the field, into your workout routine, or just back to feeling your best, ActivMend is here to speed up your healing journey.As a frequent guest on health and wellness podcasts, Dr. Jo shares her inspiring story and expert insights, helping people everywhere discover faster, more effective ways to heal...

We've all seen various hair gummy vitamins over the years, but hair health is actually much more complex than a basic multivitamin. In this episode, Dr. Herzog takes your along her hair journey exploring home and in-office treatments, supplements, products, and more. More specifically, Alma TED! Alma TED is a new revolutionary treatment that delivers growth factors and nutrients to your hair follicles via an ultrasound device. This treatment is pain free with no down time. Book a consultation with us in Scottsdale to see what Alma TED can do for you! Products Mentioned In This Episode:Plated Hair - https://perfectdoserx.com/products/plated-hair-serum-30mlSupplements! https://perfectdoserx.com/collections/desbioTimestamps00:00 Introduction02:42 Starting My Hair Transformation03:44 In-Office Treatments04:27 Alma TED vs. PRP06:36 Stem Cells and Exosomes08:31 Alma TED Results09:09 How Many Treatments Do You Need?10:11 At-Home Exosomes12:46 Supplements13:38 Getting Your Bloodwork14:32 Vitamin D315:21 Thyroid Hormone16:04 Zinc17:15 My Supplement Stack17:53 Selenium 18:28 Recap19:33 Get Bloodwork at Perfect Dose20:16 Reminder: Scalp Health is Important21:01 OutroDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

The best way to optimize your hair, face, and skin is to dial in a routine. Use the "Everything Shower" as a guide throughout each week to complete your To-Do's!Dr. Kristen starts her shower off with a 2 minute cold water immersion. This has benefits for thyroid and also makes you feel great! Next, she tackles body and facial cleanser using her favorite "Gentle Cleanser" by ZO. After cleansing comes exfoliation using silicone scrubbers - NOT a luffa! Last, the hair routine with double cleansing a couple times a week - not every day.The post-shower routine consists of exosomes for scalp health and coconut oil or bakuchiol. Check out our online store for products mentioned in today's episode.Products Mentioned In This Episode:Silicone Facial Exfoliator - https://perfectdoserx.com/collections/qyk-sonicZO Gentle Cleanser - https://perfectdoserx.com/products/gentle-cleanserPlated Hair Serum - https://perfectdoserx.com/products/plated-hair-serum-30mlBakuchiol Serum - https://perfectdoserx.com/products/bakuchoil-serumAHA BHA Cleanser - https://perfectdoserx.com/products/aha-bha-cleanserTimestamps00:00 Intro01:50 Cold Water03:56 Thyroid Levels04:51 Exfoliation 06:07 Cleansers: ZO Gentle Cleanser07:10 Cleansers: Aha Baha08:14 Hair Routine09:25 Scalp Health10:54 Shaving11:27 Post-Shower Skincare12:21 Coconut Oil13:26 Bakuchiol Serum 14:59 Exosomes16:55 Other Serums17:03 RecapDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this episode of The Rob & Jai Show, Dr. Rob Rothman and Dr. Jai Parekh host a captivating conversation with Andrew Stewart and Anthony Wallace—two leaders who are among the most experienced and admired executives in ophthalmology. Andrew Stewart, with over 25 years of pharmaceutical leadership across Bausch + Lomb, AbbVie, and Allergan, shares how his global business acumen shapes innovation in eye care. Anthony Wallace, a 26-year healthcare veteran with leadership roles at Novartis, Merck, and GlaxoSmithKline, reflects on leading Bausch + Lomb's U.S. Surgical business and his passion for patient-centered solutions. Both leaders bring a wealth of knowledge, relatable stories, and a shared commitment to advancing ophthalmic care.In this episode, you'll learn:

Women from across the country seek Dr. Danielle Dumestre out—whether discovering her on TikTok or through doctor referral — for her expertise in complex breast reconstruction. She helps women navigate options to achieve their aesthetic goals after breast cancer, often using staged DIEP flap reconstruction to restore volume.Originally from Canada, Dr. Dumestre came to the U.S. for a breast microsurgery fellowship in Dallas. She later returned home for an academic role but missed the sunshine and joined Dr. Christine Fisher's all-female practice in Austin, specializing in plastic and reconstructive surgery.Her approach is all about education, helping women understand their choices, timelines, and what's best for them. She's also passionate about aesthetics, particularly when it overlaps with reconstruction, often using lifts, reductions, and/or implants to correct asymmetry and tuberous breasts.To learn more about Austin plastic surgeon Dr. Danielle DumestreLearn more about Austin Plastic & Reconstructive SurgeryFollow Dr. Dumestre on Instagram @dumestre_plasticsurgery and TikTok @dumestre_plasticsurgeryABOUT MEET THE DOCTOR The purpose of the Meet the Doctor podcast is simple.  We want you to get to know your doctor before meeting them in person because you're making a life changing decision and time is scarce. The more you can learn about who your doctor is before you meet them, the better that first meeting will be. When you head into an important appointment more informed and better educated, you are able to have a richer, more specific conversation about the procedures and treatments you're interested in. There's no substitute for an in-person appointment, but we hope this comes close.Meet The Doctor is a production of The Axis. Made with love in Austin, Texas.Are you a doctor or do you know a doctor who'd like to be on the Meet the Doctor podcast?  Book a free 30 minute recording session at meetthedoctorpodcast.com.

Whether you have an overactive elevator muscle or an extra gummy smile, there are several treatments you can explore to help. Watch today's episode and learn about how we can lower you upper lips elevation, add volume with filler, and even apply the "Lip Flip" as part of our gummy smile treatment. Dr. Herzog breaks down treatments for two patients before and after's and even showcases her own! Timestamps00:00 Intro01:19 the Lip Flip04:36 Side Effects of the Lip Flip05:14 Severe Gummy Smile Treatment06:53 Lip Filler08:44 Addressing the "Russian Lip" Technique09:33 The Vermillion Border10:04 Using Filler the Right Way11:51 Gummy Smile Before and Afters13:32 Dr. Herzog's Before and After14:15 RecapDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Responding to leads within five minutes can make or break your med spa's booking rate. A shocking statistic from Allergan's digital consultant reveals that after just six minutes, your chance of connecting with a potential client drops by 90x. In this episode, the team explores how automation and AI-driven tools can recover lost leads, optimize response times, and maximize revenue—without increasing ad spend. Learn how a med spa recovered 543 leads and generated $47,000 by implementing a simple yet effective automated text response system. Discover the game-changing strategies that can keep your med spa ahead of the competition.   RESOURCES: https://www.partnerwithalpha.com/goodies LEARN MORE AND JOIN THE ALPHA COMMUNITY: https://www.partnerwithalpha.com/ FOLLOW ALPHA AESTHETICS PARTNERS: https://www.instagram.com/partnerwithalpha/ https://www.linkedin.com/company/alpha-aesthetics-partners/

With years of experience and continuous education on top of her NP, Dr. Kristen Herzog shares tips and facts about the aesthetic world, products, and treatments that you may have heard otherwise about. Learn about proper skincare use, filler, botox, and see her 10 YEAR before and after photos!Products Mentioned In This Episode:Bakuchiol - https://perfectdoserx.com/products/bakuchoil-serumTone Smart Sunscreen - https://perfectdoserx.com/products/tone-smart-spf-compact-4 Timestamps00:00 Intro01:13 Retinoid Use05:34 Sunscreen Use07:27 Filler Migration and Longevity12:15 Addressing Volume Loss14:41 Yes, Botox is Preventative!17:05 My 10 -Year Before and After17:35 The Term "Botox"18:25 OutroDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Welcome to the Med Spa Success Strategies Podcast, presented by Ricky Shockley of Med Spa Magic Marketing. This episode comes full circle as we welcome back Mary Beth Hagen, our very first podcast guest, to discuss one of the most critical challenges in the aesthetics industry. If you're looking to build a strong, ethical, and talented provider team in your practice, this episode is a must-watch! In this episode, we talk about... ✅ How to recruit, retain, and develop top-tier injector talent for your med spa ✅ The key qualities of high-performing aesthetic providers ✅ The TITAN Aesthetic Screening Protocol and how it identifies top injectors ✅ Strategies to ensure patient safety and deliver natural results ✅ The importance of foundational training and peer education in aesthetics ✅ How to create a strong, ethical, and talented provider team ✅ Proven methods to enhance provider retention and practice success & more! If you're ready to implement more efficient & effective marketing strategies for your practice, book your FREE strategy session & marketing plan: https://go.medspamagicmarketing.com/schedule About Mary Beth Hagen of TITAN Aesthetic (https://www.titanaesthetic.com/) Mary Beth Hagen is the founder of TITAN Aesthetic, dedicated to supporting great injectors and practices in achieving the best patient outcomes. With a background at Galderma and Allergan, Mary Beth brings extensive expertise in both the clinical and business aspects of aesthetic injectables. Through TITAN Aesthetic, she helps identify and train the next generation of injectors, ensuring they have the skills, communication, and ethical foundation needed to thrive in the industry. Her mission is to elevate patient care by equipping providers with the right education, training, and ongoing support. Follow Mary Beth on Instagram: https://www.instagram.com/titan_aesthetic_mbhagen/ Training Resources from Mary Beth: mbhagen@titanaesthetic.com https://www.titanaesthetic.com/

The nasolabial folds, referred to as smile lines, are mostly a result of long term mechanical trauma to the skin. Today Dr. Kristen Herzog discusses how this trauma can be reduced and how you do minimize these fine lines and wrinkles over time. Of course, surgery is the MOST effective treatment, but even after surgery you will want to learn these tips to care for your investment! We talk at-home, in-office, low budget, high budget, and lots more.Products Mentioned In This Episode:Sunscreen - https://perfectdoserx.com/search?q=colorscience&options%5Bprefix%5D=lastBakuchiol - https://perfectdoserx.com/products/bakuchoil-serumTNS Advanced Serum - https://perfectdoserx.com/products/tns-advanced-serumTimestamps00:00 Intro01:06 What Are Smile Lines?02:10 What Causes Smile Lines?06:41 At Home Treatments07:07 My Favorite Sunscreen07:57 Retinoids08:30 Retinoid Alternative - Bakuchiol09:10 Growth Factors10:03 Face Taping (Especially for Side Sleepers)10:50 Red Light Therapy11:21 Filler12:58 Biostimulators14:30 PDO Threads16:58 Finding Your Expert Injector17:45 Skin Tightening18:31 Morpheus + FaceTite20:56 Pain Management21:21 OutroDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Isabella Schmitt is a prominent life science, AI, and regulatory affairs leader, and was recently named one of the top 100 MedTech Leading Voices Worth Following on LinkedIn in 2025. Isabella shares her diverse career journey—from aspirations of neurosurgery to becoming a regulatory expert in MedTech and biotech. She emphasizes the importance of early regulatory involvement, strategic use of pre-submissions, and understanding the voice of the customer in product development. Isabella also discusses the critical role of communication skills in regulatory affairs and offers invaluable advice for aspiring professionals.   Guest links: https://www.linkedin.com/in/isabella-j-schmitt/ Charity supported: Polaris Project Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 048 - Isabella Schmitt [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello, and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey. And today I am so excited to introduce you to my guest, Isabella Schmitt. Isabella is a life science, artificial intelligence and regulatory affairs leader with expertise in navigating the intersection of science, technology, policy, and innovation. With a robust background in medtech and biotech regulations, she has contributed to over 200 projects ranging from hardware and software medical devices to AIML products. Isabella holds an MBA from Texas A& M and is pursuing advanced studies in AI management and policy at Purdue University. Known for her engaging communication style, she is a sought after speaker, author, and consultant on AI regulation and innovation. All right. Well, welcome to the show, Isabella. I'm so excited that you're here. [00:01:41] Isabella Schmitt: I'm excited to be here. I feel like it's been a long time coming as we just talked about a second ago. We've been needing to connect for a while so I'm glad we're finally getting to do it. [00:01:50] Lindsey Dinneen: Me too! Well yes. Thank you for taking some time today. And I wonder if you would be willing to start off by sharing a little bit about yourself, your background and actually what led you to medtech. [00:02:00] Isabella Schmitt: Yeah. So it's an interesting story because I actually have a pretty varied background in general. Like if we start back, back in high school, even so we'll go that far back, I wanted to be a neurosurgeon originally in life, and... well, originally I wanted to be marine biologist, but that was when I was in elementary school. No, I wanted to be a neurosurgeon probably from the time I was like, 14 to like, 21. And then I did a surgical externship and I didn't love it. And so then I had a quarter life crisis where I was just like, "What do I do? This is what I've wanted to do for so long." And then I found myself going into research, so I did a lot of lab work in primarily healthcare type things. So, with nanomaterials for oncology, you know, specific targeting of tumors and things like that. But then I found with that, I liked the design of the experiments and like the design of new inventions and all of that, but I didn't actually enjoy the lab work. So like the actual part of being a researcher was not fun for me. And so, I shifted gears, had a little kind of a stray off of the, this normal trajectory, I guess. And I was like, "Oh, well, maybe I want to do veterinary medicine." I love animals, so I did that for a little bit. And then I felt like there was always this drive for me to do something that felt good, aligned with my values, right? But was also intellectually stimulating so that I felt like I was constantly challenged. There was something new. It was very diverse. A little bit of ADHD there, right? So like I need, I need lots of inputs and stimuli. And so I, with veterinary medicine, I felt like I really liked this. It was ticking the sort of values box, but it wasn't really ticking the other boxes for me. And so then I kind of went back and was like, "Well, maybe I want to go to medical school. I'll revisit that." So I took a job at a pharma company, a midsize biopharma company. And I started off in the clinical research side. I didn't know anything about the industry at this point, 'cause they don't really teach you anything about biopharma or medtech in school. I don't even know what I thought about how products like drugs and devices got to market. I just kind of assumed someone was checking over that, I guess. And so I had no idea and I took the job thinking it was more truly clinical related. Like, I was going to be, I don't know what I thought I was going to be doing, but something clinical, and it was, it was a CRA position. But what they noticed about me, was that I started trying to analyze the patient data and I unblinded myself in doing that. And so they were like, okay, well, maybe you need to do something that's a little bit, not that there's, you know, that being a CRA is not intellectually stimulating, but not in alignment with exactly where I was. And so they put me towards regulatory affairs. And so I started helping kind of just general regulatory affairs. Then the guy that was running the product side of things, all the manufacturers and getting the product ready, was retiring. And so they promoted me to that position. And so what was happening at that time was I was getting intellectually stimulated. I was doing well. It had the diversity that I liked where it was ticking the altruistic box and helping people and it's, you know, scientific, it's medical, it's writing, it's reading, it's understanding. And so it was kind of scratching that itch for me, so I didn't go back to school. I well, actually I did, but that's later down the line. But I, I stayed there. That company got bought by Allergan and I left at that point and I went to a medtech startup company and that was my first foray into medtech. So I moved from biotech to medtech. And, you know, some of those things can translate, right? The cultures between biotech and medtech are very different, but a lot of the foundational knowledge of how you think about things can translate. So at that company, I learned more about medtech, but I could apply the biotech lens to it, which I think ultimately helped me from a strategic standpoint in the medtech world. And then I left that company and I started at Proxima, which was the company where I first met you. And I was like employee four there, and I ultimately built their regulatory consulting group and that whole kind of department from me to 15 people and over 200 projects. Loved working there. I did a lot of talking, BD, consulting, all kinds of things. I then started running their clinical department as well, and then I left Proxima and now I work at a AIML company as their VP of clinical and regulatory. So I manage all of their suite of products for global submissions and kind of all the clinical collaborations that are ongoing there. There's a long background, but it's a trajectory and I feel like people feel like they need to know what they're going to do at some point, like early on. And when you go to college, you're like 18, you don't know, and you barely know about what's out there, right? But you feel like 'I should know the answers to all of these things,' and you don't. And sometimes you find yourself in places that you didn't really expect and I know that a lot of people also want to get into regulatory affairs, and it is difficult sometimes to get your foot in the door. It's a competitive type of role largely because it, it is so diverse and stimulating and you have to have a lot of different types of skills to actually be successful in it. But, you know, what I would suggest people do is look for smaller companies to kind of go towards, because those are the types of companies that'll maybe take a chance on you with leadership that helps and guides you through that transition. So when I was running Proxima, I like to hire people kind of earlier in their career because one reason was selfish. You don't have to reteach or get them out of bad habits, right? And then the other part was I just liked kind of, I liked the, the helping and the molding and the growing of them. And it's really nice to see them be successful there or afterwards as they move on into other places. And we have lifelong relationships now. You know, I've left and I still talk to them and they still come and they ask me for advice about things. And so that's really nice. [00:08:42] Lindsey Dinneen: Yeah, that's incredible.,Well, first of all, thank you for sharing a little bit about your background. That was really cool to hear about your career trajectory and so many things popped up for, for me right away. But one of the things that really stood out was this idea-- I love how you talked about the fact that you don't have to know at the very beginning of your career or really, I don't know, even in the middle of it, is this what I'm going to do for the rest of my life? I mean, it's okay to kind of. stumble into a path you didn't expect and see where it leads you. And, I'm curious too, you know, you've had such an interesting, diverse background and you've had all of these different skill sets. So when you first started, I know throughout different places you've been, you've done a lot of business development, but can you share a little bit about the skillsets and the things that you've learned through business development that actually really do translate to... Yeah. [00:09:35] Isabella Schmitt: So, so business development is... so weirdly I had this sort of side thing where I was doing marketing work kind of just as like a side hustle for a bit. And so at Proxima, I really helped with market. So, business development and marketing, particularly for the consulting side of things reported into me as well. So I did a lot of that work, and I think in those cases, business development and marketing, if you're good at it, is all about communication, right? Like, it is about communicating effectively with other human beings, whether that's through talking to them or through writing. And understanding the audience that you're talking to, whether it's talking to them or through writing. So, you know, in a conversation, you get good at reading people, right? Like you can kind of hear what they're saying and you start to learn like, okay, this is their pain point. They're saying this one thing, but what I'm getting from it is this other thing that I know a little bit more about that they're not necessarily picking up on. And so you, you start to be able to take on more of an advisory role, I think? There's different approaches to sales and marketing, right? There's the hard sales approach where it's like sell, sell, sell, which is, there's nothing wrong with that. It's just not my approach to business development and marketing. Mine is much more advise, educate, relationship. What is it that you actually need? How can I meet your needs? And I think that skill set translates really well into regulatory affairs. There's different types of ways you can be involved in regulatory affairs. If you're doing high level strategy type things, you need to have these communication skills. You need to be able to see the forest and the trees and be able to redesign a forest if you need to. But there's also the very by the book administrative side of regulatory affairs where I think these skills probably aren't as necessary and there's nothing wrong with that. Some people really like that sort of structure. I'm not that way. So I really like the strategy communication talking aspects of it. And I think the business development and marketing, the crux of it all is the communication aspect. And that is incredibly important when you're pulling together regulatory submissions, and you're engaging with regulators, you need to understand your stakeholder there, who you're talking to, the audience, what they're interested in what they're not interested in and be able to read that in that instance as well because you want to give them enough information, but not too much information about what it is that they need to understand in order to clear or approve your product. For the people that I would bring in, you know, when they were early in their career, I think them being in a more of a consultative environment was probably beneficial to them in the long term because they had to learn those skills in the context of engaging with clients, right? And so we would do different things, you know, as they were training, I would be on the calls with them, but sometimes we'd do sort of like the mic in the ear thing, but through Teams, I would send them messages like, 'say this, ask them that.' And then I would explain, you know, or if I said something that seemed unexpected, you know, like that was a different direction from the conversation or they expected me to respond to something that I didn't respond to, I would explain it to them afterwards so that they could learn and kind of absorb those skill sets so that they could then take that forward and apply it whether it's with clients or with regulators, or just with teammates, whomever it is moving forward, they would understand the communication aspect is so incredibly important in the strategic side of regulatory affairs. [00:13:38] Lindsey Dinneen: Yeah. Yeah. Yes. Thank you for, for sharing more about that. I can absolutely see the critical importance of the communication skills, being able to translate, but, but building those skills. And honestly, it's probably just great advice across the board. You know, anyone, especially young in their career. Those are the skills to build. [00:13:57] Isabella Schmitt: Yeah. [00:13:58] Lindsey Dinneen: Yeah. [00:13:59] Isabella Schmitt: Yeah. [00:14:00] Lindsey Dinneen: So. [00:14:01] Isabella Schmitt: Nothing, nothing better than relationship building and communicate and clear communication in your personal life, in your professional life, everywhere. So, yeah. And I think, you know, it's interesting too because there are things about my childhood and growing up that also translated into having a skill set associated with communication and understanding people and dynamics that was like a long term training, you know, from being a little kid to now, which maybe not everybody gets and that's okay, but they can learn it. It's something that, it's learned. It's not innate. You can learn it at any point if you're willing. [00:14:48] Lindsey Dinneen: Yeah, I, I love that. So, you know, okay, so now you've had all this incredible experience. You've helped a lot of companies and, you know, regulatory affairs is your jam. What kinds of things do you see that are kind of common, perhaps stumbling blocks for, especially smaller medtech companies that are trying this for the first time and this is their big hurrah and it's really exciting, but what are some things that you see that, that maybe we could help mitigate? [00:15:16] Isabella Schmitt: Mm. Yeah, I think the first things that come to mind and it's kind of like two opposing flavors. One, is... and they're both around pre-subs, right? So pre-subs are the big talking point, I think, all the time, and you will often hear people say like 'just do a pre-sub 100 percent of the time.' I think generally, that's true. There are cases where you don't necessarily need to do a pre sub. But as you go into a pre sub, it's again about communication. You want to make sure that you're not saying something that you can't get yourself out of in the future. So, like, you know, oversharing or oversharing erroneously too. You can share things that maybe are not particularly relevant to what you need to convey but then can cause a flag that sticks in the minds of the reviewers. So you want to go to a pre sub typically with someone who has done them before successfully, and you probably want to find, if you're an innovative company that's doing this for the first time, someone who works with innovative companies a good bit more on the strategy side, even if they're not the one that's writing the pre sub, but that it is overseeing the sort of process with it. Like I said, there's, there's a very administrative side to regulatory affairs too, and there are people who can turn, turn, turn submissions out and that's great. But when you're dealing with an innovative type product, that sort of administrative part of it== it's still important, but it becomes less important-- because you're basically navigating a new landscape and you need someone who has done it before, who can kind of understand how the regulators, whether it's FDA or notified body might think about it so that you can convey the information adequately or answer their questions adequately too. The flip side of it is... so do a pre sub, but do it smartly. The flip side of that is don't do too many pre subs. So one of my friends in the industry and I were just talking recently about ' death by pre sub,' where you do so many pre subs that you've kind of painted yourself into this corner and you maybe don't want to be in that corner and you have to figure out a way to kind of claw yourself out of it. It, it can become very restrictive. So if you go, you know, if you're on pre sub eight, you're probably too far, too far or too deep in at that point. So you want to be smart about the pre-subs and generally speaking, I think that was the first comment, death by pre-subs is usually if you're not being smart about the pre-subs. And then I think people go in maybe without a pre-subs at all thinking that, "Oh, I have a 510 K. It's straightforward." Maybe they're using a predicate. If your predicate's really old, they may have changed their thinking on it, so you probably still want to do a pre-sub even if it seems straightforward. Those are the things that I think are are probably major pitfalls. I'd also say companies not involving someone with regulatory expertise early enough on, so even if you're not engaging with FDA, companies can get kind of stuck in a perpetual loop of product changing and advancement to the point that is detrimental and that a lot of that doesn't actually help in the long run, from a regulatory standpoint, understand your minimal viable product. And then from there, once you understand what that is, right, then you should really start engaging someone who has regulatory expertise. Or maybe you need someone to help you figure out what the minimal viable product is through, you know, some sort of regulatory lens as well. But I wouldn't spend 10 years going through design iterations and all of that before you get someone in to level set with where you are from a regulatory standpoint, [00:19:31] Lindsey Dinneen: Mm hmm. [00:19:32] Isabella Schmitt: And then I think shifting a little bit from regulatory, also involving regulatory and clinical, is understanding the voice of the customer. You design a product, you kind of want to design a product that people want and will use, because you can get through regulatory right? But if nobody wants that product, you've wasted years developing it, and a lot of money, and so getting with whoever the, the end user is going to be and understanding what their actual needs are and having them kind of look and touch and feel the product is, I think, incredibly important, even in the earliest stages, because you don't want to spin your wheels, designing something that nobody ultimately wants or can use. [00:20:19] Lindsey Dinneen: Yeah, absolutely. So design with the end user in mind, talk to the end user in mind, and then talk to an expert such as yourself to really help guide you through that regulatory process. And it sounds like the earlier the better just to start that process going so you have an idea of where you need to head. [00:20:39] Isabella Schmitt: Exactly, yeah. That's exactly right. Yeah. [00:20:41] Lindsey Dinneen: Yeah, excellent. So, you know, you have had such a very cool diverse background and, you know, you've been honored a lot. You're, you know, a Houston Woman to Watch. You have gotten a business award, multiple ones. You just recently got named to MedTech Leading Voices, you know, 100 MedTech Leading Voices. That was really cool. So congratulations. [00:21:02] Isabella Schmitt: LinkedIn's been blowing up from that. I was like, yeah, [00:21:06] Lindsey Dinneen: That's awesome. Yeah. [00:21:07] Isabella Schmitt: I haven't looked at it on my own LinkedIn yet. And it's, I opened it today. I wasn't on it all weekend and I had like 50... [00:21:14] Lindsey Dinneen: Oh! [00:21:14] Isabella Schmitt: ...requests. I was like, what? So yeah. [00:21:17] Lindsey Dinneen: Amazing. Well, congratulations! That's really exciting! [00:21:21] Isabella Schmitt: Yeah. [00:21:21] Lindsey Dinneen: You know, like, just looking back, could 10 year old Isabella have ever anticipated this is where you would be right now? [00:21:29] Isabella Schmitt: No. Well, you know, not exactly, but I was Student of the Year when I was 10, so maybe that was an early hint, I guess. [00:21:42] Lindsey Dinneen: I love it. [00:21:43] Isabella Schmitt: Yeah. [00:21:44] Lindsey Dinneen: Yeah. [00:21:45] Isabella Schmitt: Yeah, 10 year old Isabella I don't know. 10 was a weird age. [00:21:51] Lindsey Dinneen: Yeah. Fair enough. Fair enough. [00:21:54] Isabella Schmitt: I definitely wouldn't have seen myself in this industry and even, you know, 18 year old Isabella wouldn't have seen myself, because I didn't know it existed, [00:22:03] Lindsey Dinneen: Right. [00:22:04] Isabella Schmitt: But, you know, being highly on the business side of things too, because regulatory is very deeply integrated with all should be with all aspects of a product, right? And so I have to understand the voice of customer and I have to understand if there's a market for this and I have to understand the engineering and be able to translate all that information and, you know, and then on the other side of it with Proxima, I built the actual business. So, you know, I had to design pricing strategy and marketing stuff. And so I never really saw myself being so heavily involved in the business world and that may have like honestly come from, not to get all political or whatever, but like a lens of sort of my vision of business person was male, you know, and so I just didn't have a lot of exposure to women in, in business roles and I don't, I don't think I ever had imposter syndrome because I always felt pretty confident in my abilities. I felt more like the world of business was male dominated, which it largely probably still is. But, but I think that kind of maybe held me from having that vision. And I mean, surgeons are male dominated too, but I was thinking I was going to be a surgeon. So, so, but I also had a vision of the business world as being more like Wall Street kind of world. And you grow up, you know, and you learn new things and get exposed to new people. I'm very thankful for the people that I have met who have given me opportunities to, to shine, I guess who have trusted me, like Kevin with Proxima trusted me to build the department. The company that I work for now basically trusts me to do all the regulatory stuff. Obviously, hundreds of clients have trusted me with their regulatory, with their babies. So it's one of those things where it's a combination of your own aptitude, but also other people. And, and I think for me, and that's why I wanted to also bring in, you know, green people who are coming new into the industry, to give those people opportunities to live up to their potential too, because a lot of it is having the opportunity and having someone trust you in order to, to show what you can do or can't do, I guess, but you learn either way, right? Failures are learning opportunities too. So. [00:24:40] Lindsey Dinneen: Yeah. Well, I love that because you, you saw people, you know, 'cause sometimes it feels, especially as a job seeker, if you're young, or you don't have the industry experience, it just feels so invisible. So I love the fact that you were willing to do that. And then mentorship sounds like a really strong pull for you. Like, you very much care about that and helping the next generation of folks... [00:25:02] Isabella Schmitt: Yeah, yeah. [00:25:02] Lindsey Dinneen: ...find their footing too. So I love that. [00:25:05] Isabella Schmitt: I, I love doing that. And I was teaching at Rice. I would teach a lecture a semester at Rice when I was at Proxima, maybe I'm going to do it now, I don't know. And then A&M a little bit too, and so even just kind of meeting students, I just, I like to give people opportunities, so if people are listening to this and they want to understand how to get into regulatory affairs or really anything, I am happy to have a conversation. Lindsey will tell you that I might reschedule it, but I will have the conversation. [00:25:40] Lindsey Dinneen: I can attest to this. She will, she will. Absolutely. [00:25:43] Isabella Schmitt: I do want to do it. It's just, yeah. [00:25:49] Lindsey Dinneen: MedTech has become sort of, at least it sounds like your calling, for lack of a better word. And so I'm curious, you know, you are obviously very passionate. You are one of the leading voices in the industry. You are a thought leader. Along the way have there been moments where you just thought, "Wow, this really cinches it for me. I am in the right place at the right time doing the right thing." [00:26:11] Isabella Schmitt: I mean, I think, in general, I feel that way. I, I'm the type of person who, though, is kind of always looking to grow and advance and more and more and more. And so I think it's, it's always kind of a learning experience. I think I will stay in this industry till I die, but for for a long time and it kind of just like, it clicks in my brain. Like, it just, it sort of makes sense with how my brain works. But, you know, I have also expanded a little bit into AI kind of generally speaking as well. So, I work at an AI company now and I've worked with many AI products before. But I also am in a master's for AI, and I've been doing some policy work with it. So I, I try to, I try to go deep and broad at the same time, which I think is hard and maybe tends towards workaholism, workaholicism? But, but it keeps me stimulated and feeling like I'm productive and moving forward. And so, you know, I, I guess, to answer your question succinctly, I do think I've found a place that I really love. I think that I will continuously look to expand and grow, just how I am, whether that's in specific with regulatory affairs or whether it's spinning off another consulting company or whatever, you know, my own product company one day, whatever it might be. I think this space is what I like. And I, I like growth personally, and I like growing people and I like growing businesses. So I think all of that, I guess if there was a moment, honestly, Proxima. My experience at Proxima with growing, growing there, myself, the company, clients, employees, marketing, whatever it was that, that probably sealed the deal for me staying and not kind of looking to do something else. There was a short stint where I was very confused again before I started at Proxima. I was like, "I don't know if this is right for me." I was thinking about leaving the industry and going and doing psychology and all of that. And, I got the job at Proxima, it just kind of checked everything for me. And so I think that, that, you know, if you're a person that likes a lot of diversity, I think getting into a strategic regulatory affairs role, particularly if you're able to work with multiple companies is, is the sweet spot. But yeah, that was one of the best places I've ever worked, one of the best experiences I've ever had. [00:29:02] Lindsey Dinneen: That's incredible. Well, great. I'm so glad and thank you for sharing about that experience. Yeah, that's wonderful. So, okay, pivoting the conversation a little bit just for fun. Imagine that you were to be offered a million dollars to teach a master class on anything you want. It can be in your industry, doesn't have to be at all. What would you teach? [00:29:21] Isabella Schmitt: would I would probably teach AI policy with specific towards regulated industries. So meaning, obviously, medtech, biotech to o, aviation, aerospace defense. So I kind of want to take it, sort of a broad approach, of how we think about regulatory with regards to AI, and the differences in regulating that type of product versus more standard types of products. So, that would probably be what I would would like to do if I were teaching a master course. [00:30:06] Lindsey Dinneen: That sounds incredible and very needed, very timely. [00:30:10] Isabella Schmitt: Yeah, [00:30:11] Lindsey Dinneen: Yeah. Excellent. How do you wish to be remembered after you leave this world? [00:30:18] Isabella Schmitt: That's a big question. So, and it's a tough question. I want to have made an impact on the industry, on people's lives, on an industry because, you know, with AI, it could be multiple industries, I guess, too. Probably sticking closely with medtech. It's what I like, and it feels like the best again, like value kind of. I think if I were to like make up this dream scenario of where I ended up, eventually I would have my own product company. I would sell that off. I would probably start another consulting company that I helped people with still. And then I would do like philanthropic things with money. And largely focused probably on pediatric type devices, rare diseases and conditions, and probably veterinary medicine, which those areas I don't think get enough attention. I have a lot of experience with with pediatrics in particular and I think I would like to be able to work closely with getting more of those products to market. They're, you know, difficult funding opportunities there because such a small, still large burden, but such a small group of patients that the ROI is not typical of what you would see, you know, a lot of VCs investing in. So something like that, I think, and being remembered for those, those things, I think, would be great to me. [00:31:50] Lindsey Dinneen: Yeah. [00:31:51] Isabella Schmitt: Also, if I influenced policy in some kind of way that was fundamental, I think that would be pretty cool too. [00:31:57] Lindsey Dinneen: Absolutely. Yeah. Very cool. And then final question. What is one thing that makes you smile every time you see or think about it? [00:32:06] Isabella Schmitt: Oh, that's a good question. Not work related or work related? [00:32:10] Lindsey Dinneen: Oh, both, either. [00:32:12] Isabella Schmitt: I, probably my dogs would be, that's an easy not work related answer, although sometimes they drive me nuts too. So there's a spectrum of emotion with them, but generally dogs. Dogs are just the best. I'm, I'm a dog person. They're just so loving and understanding. Work wise, obviously, anytime I have a successful submission, or there's an exit, any success, it always makes me smile. So, and then, you know, I also really like-- I haven't been to many over the last year, just with the change and the dynamics of my world-- I love networking events. So, like, thinking about networking events, I just, I really enjoy those types of interactions. They've always been really fun. I've been thinking about going to them just for fun, just to see people again because it's been a while. And I used to love, like, my favorite thing was Medtech Innovator. So I'm answering this question, and I'm thinking of the answers I'm talking about. So MedTech Innovator, I love MedTech Innovator. It was almost like when you're a kid, and you go, and you have the summer off, and you don't see anybody or any of your friends, and then you go back to school, and you're sort of excited to see them again. That's what that community felt like, really to know the people there so well. So MedTech Innovator, that's my answer. [00:33:35] Lindsey Dinneen: I love it. Great answer. Great answer. Fantastic. Well, oh my word, this has been so much fun. Thank you so much for taking some time today just to share with me about your life and your experience and all the wonderful things that you're bringing to the world. I just really appreciate it. And, just thank you for your time. [00:33:56] Isabella Schmitt: 'Course, thanks for having me. [00:33:58] Lindsey Dinneen: Yeah, and we are so honored to be making a donation on your behalf as a thank you for your time today to the Polaris Project, which is a non governmental organization that works to combat and prevent sex and labor trafficking in North America. So thank you for choosing that organization to support, and I just wish you the most continued success as you continue to work to change lives for a better world. And just also thanks to our listeners for tuning in. And if you're feeling as inspired as I am, I'd love it if you'd share this episode with a colleague or two and we'll catch you next time. [00:34:36] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo are live from the Hawaiian Eye meeting with guests Paul Singh, MD, Candy Simerson, Jeffrey Goldberg, MD, PhD, and Roger Goldberg, MD, MBA. Welcome to the Eyeluminaries podcast :02 Review of episode 30 3:23 Intro of Paul Singh, MD 3:40 What are the future trends in glaucoma you're most excited about? 5:10  What challenges do you see in running your practice that didn't exist in your dad's day? 8:36 You've got a great medical office, a very busy consulting and research practice, you play in a band and you have a young family. What advice would you give others in keeping it all in balance? 12:09 Besides your dad and the two of us, who do you look up to in eye care? 14:45 Singh sings a Funkadesi song 18:16 Intro of Candy Simerson 20:36 When you come into a new practice to consult, what are the most common areas you see where improvement can be made? 21:41 What about the finances? What areas in finances do you see where improvement can be made? 24:27 In your many years in ophthalmology, what are the biggest challenges you've experienced? 26:10 What type of practice should consider a sale to private equity? What type of practice should not? 29:34 What advice would you give a company representative who wants to win business from a big ophthalmology practice? 32:29 Intro of the Goldbergs 36:25 Jeff Goldberg, MD, PhD 36:50 Roger Goldberg, MD, MBA 37:21 Jeff, why glaucoma instead of retina? 38:43 Roger, why retina instead of glaucoma? 39:37 Mazzo discusses neuroprotection in retina and glaucoma. 41:14 What is entrepreneurship like today? What's your advice? What is challenging and what is positive? 43:10 Mazzo discusses being realistic about innovations. 48:30 What is private practice like today? 49:31 How do cornea specialists better understand glaucoma specialists? 53:05 How do cornea specialists better understand retina specialists? 54:13 Tell us about emmecell. 55:50 Preview of episode 32 59:19 Give us your feedback 1:00:18 Thanks 1:00:30 Jeffrey Goldberg, MD, PhD, is professor and chair of ophthalmology at the Byers Eye Institute at Stanford University and a member of the National Academy of Medicine. Roger Goldberg, MD, MBA, board certified by the American Board of Ophthalmology and is an active member of the American Society of Retinal Specialists, the Retina Society and the American Academy of Ophthalmology. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Candy Simerson is the senior vice president of practice operations at Vision Integrated Partners. I. Paul Singh, MD, is the president of The Eye Centers of Racine & Kenosha, Ltd., founded in 1981 by his father, Dr. Kanwar A. Singh. He is a founding member of the band, Funkadesi, a mix of Indo-Afro-Caribbean style music. The band tours the world spreading the message “one family, many children.” We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for the Goldbergs, Simerson and Singh at the time of publication.

Injectables | Skincare | Gadgets | LED and laser | Regulations in aesthetics | Make-up | Surgery | Body treatments | Tricky areas | Ultimate tips | Brand recommendations | Sleep and supplements

As we age, the areas around our eyes slowly change too. Due to facial fat changes, skin stretching from gravity, and loss of collagen, our eyes start to look hooded, saggy, and wrinkled. Aside from surgery, which is very effective when done correctly, there are a few things we can incorporate into our habits that will reduce this aging around the eyes. Products Mentioned Undereye Growth Factor: https://perfectdoserx.com/products/growth-factor-eye-serumTimestamps00:00 Intro01:45 Eye Comparison02:49 Mechanical Trauma04:56 Facial Fat and Skin Laxity06:33 What Can You Do About It?08:06 Eye Creams To Use09:31 Surgery Options11:01 CO2 Lasers (In-Office Treatments)12:28 PRF / Exosomes - Growth Factors!13:28 Pretarsal Injection14:12 Combining Everything For Best Results14:50 SummaryDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Got a show or guest idea? Send us a text!Find Dr. Jo and ActivMend here: https://activmend.com/Connect with Erin Paige here: https://heartwinghealing.comDr. Jo Polich was satisfied with her career as an engineer, leading successful projects at IBM and Alcatel, until her daughter got sick. She took her to specialist after specialist, but no one could figure out how to treat her toddler.In desperation, Dr. Jo bought her daughter a natural remedy. For the first time in a year, her daughter's digestive issues disappeared.Curious, Dr. Jo researched more remedies and their efficacy. She decided to leave her position as Director of Engineering and devote her time to caring for patients. She earned a medical degree and opened her own practice, delving into the science behind the treatment.Dr. Jo's first high-potency hydrogel, OcuMend, won over many respected dermatologists by healing their patient's bruising and pain. Their support was so convincing that Allergan licensed the technology for cosmetic dermatology. This was the first ever licensing of an arnica product by a major pharmaceutical company. ActivMend improves on Dr. Jo's original formula to help athletes, like you, get back to your sport, your routine and your life at full speedSupport the show

Today's episode if all about pregnancy. Dr. Kristen Herzog shares her journey of fighting PCOS and Thyroid issues to get pregnant. Thanks to these lifestyle changes, she is now pregnant again! The lifestyle changes discussed include exercise, diet, and eliminating toxic products. She also gives guidance on how to use skin products safely as a pregnant women.GET 15% OFF BAKUCHIOL SERUM! Use Code "PDPOD"Products Mentioned In This Episode...Bakuchiol Serum - https://perfectdoserx.com/products/bakuchoil-serumComplexion Pads by ZO - https://perfectdoserx.com/products/complexion-renewal-padsTonic by PD Rx - https://perfectdoserx.com/products/tonicTimestamps00:00 Intro02:48 PCOS - Polycystic Ovarian Syndrome03:24 Birth Control06:07 Insulin Resistance07:00 Keto Diet09:45 Exercise Changes10:46 Berberine12:22 I Got Pregnant!13:40 Relying on Big Pharma14:12 Post-Partum Depression16:04 Thyroid Problems17:59 Correcting My Thyroid19:16 Cold Plunging20:38 Eliminating Toxins From Your Life21:59 Getting Pregnant Again23:22 Skincare During Pregnancy 27:50 15% OFF My Bakuchiol Serum28:07 Summary28:38 Bonus Tip - Get A Diamond Glow Facial In Office!Don't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Mike Clague is an aesthetic nurse, with a Bachelor of Science.  He is the CEO and founder of Face Coach, a consultant, a speaker, an author and has a wealth of  knowledge in the aesthetic space.   Beginning his career in medical aesthetics with Allergan, the makers of the world's leading anti-wrinkle injection, Mike enjoyed learning techniques from some of the best injectors globally over his 6 years with this prestigious company.   He has trained over 1000 doctors and nurses in the art of injecting muscle relaxants and dermal fillers across Australia, New Zealand, Thailand, India, Malaysia and the Philippines.   Hanya Oversby has known Mike forever, having worked with Aesthetic doctors, nurses and companies for many years.  Their chat was wide ranging and engaging – enjoy!   For more information on Mike, please see below: https://www.mikeclague.com.au/mike-clague Medical grade skin care. - Faceloveskin.  hello@faceloveskin.com.au   https://www.faceloveskin.com.au   Hair regrowth, eyelash growth products – hello@loqhair.com.au   https://loqhair.com.au   Courses for injectables or consultation process – hello@waytogrow.com.au    www.mikeclague.com.au   For patients -  hello@facelove.com.au    www.facelove.com.au Twitter - @mikeclague   Instagram - @claguemike   Email mike.clague@waytogrow.com.au   Phone 0450661284   More information about Hanya Oversby can be found on https://hanyaoversby.com.au/

Rabbi Richard Louis Price, M.D. is a Yale & Columbia University-trained psychiatry professor at Weill Cornell Medical College/New York-Presbyterian Hospital. Over the past two decades, he has evaluated over 20,000 patients serving as a medical director at Achieve Behavioral Health in Monsey; Rockland TMS & Wellness Center; Hamaspik of Orange and Rockland Counties; Volunteer Counseling Services in New City; ParCare in Brooklyn, Chai Urgent Care Centers of New York, Pennsylvania, and Florida,, and has a private pediatric and adult psychotherapy and psychopharmacology practice in Monsey, New York. Dr. Price is triple board certified in Psychiatry, Consultation-Liaison/Mind-Body Medicine, and Addiction Medicine and has been awarded numerous patents in the United States, Canada, Europe, and Israel for a novel pharmacotherapy for the treatment of both core and associated symptoms of Autism Spectrum Disorder. Dr. Price has served on the advisory boards and as a national speaker for several pharmaceutical companies, such as Abbvie, Alkermes, Allergan, Almatica, Axsome, Idorsia, Intracellular, Janssen, Jazz, Lumbeck, Neuronetics, Otsuka, Supernus, and Vanda and has been recognized as a top Medical Educator by the American Psychiatric Association. He is also a professional singer and taekwondo black belt.     ADHD ARTICLE PUBLISHED: https://pmc.ncbi.nlm.nih.gov/articles/PMC10374479/ HISTORICAL OVERVIEW OF VILOXAZINE: https://pmc.ncbi.nlm.nih.gov/articles/PMC8219567/  

Have you ever wondered how much money and what procedures it would take to have a facial balancing transformation?My beautiful patient came in looking for a facial balancing treatment plan after having some filler migration, so I evaluated ALL aspects of her face. In today's episode we break down each part of her face, the cost, the timeline, and how each patient's situation may vary depending on anatomy and budget.00:00 Intro01:26 Give Me Your Feedback!02:02 My Beautiful Patient03:36 Jaw Muscles05:15 Frownlines06:44 How Much For All This Botox?08:37 Botox Resistance09:40 How Long Until You Get The End Result10:14 Dissolving Lips 11:15 Where I Injected Filler13:58 Total Filler Cost15:10 How Much For Full Facial Balancing?17:22 Sculptra - How Much Is It?18:20 This Patient's Maintenance CostsDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In the latest episode of Skin in the Game VC, Tom Wallace and Saxon Baum welcomed Brent Saunders, Chairman and CEO of Bausch & Lomb, to share his journey and insights into leadership, healthcare innovation, and the power of investing in groundbreaking ideas. From his early days as student body president at the University of Pittsburgh to overseeing multi-billion-dollar deals in the healthcare industry, Brent's career is a masterclass in strategic thinking and execution.Brent reflected on his experience leading companies like Allergan and Bausch & Lomb, where he navigated complex mergers and acquisitions totaling nearly $300 billion. His approach centers on aligning deals with a strong strategic rationale and financial discipline, ensuring long-term value creation rather than short-term gains.A recurring theme throughout the conversation was Brent's passion for leveraging technology to tackle inefficiencies in healthcare. He highlighted the potential of AI to transform drug discovery and streamline clinical trials, sharing how his company uses AI to identify solutions for challenging diseases. Brent also emphasized the need for universal, portable medical records to improve patient outcomes and reduce systemic inefficiencies—a vision that remains elusive but vital for the future.As an active investor, Brent shared his enthusiasm for backing startups that prioritize innovation and have strong, experienced teams. He cited Roam, a Miami-based tech startup led by Howard Lerman, as an example of a company combining cutting-edge ideas with proven leadership. Brent underscored the value of working with founders who have “climbed the hill before,” noting that their experience and resilience often set them apart.Looking to the future, Brent offered predictions on market trends, including the growing influence of AI and the expected resurgence in mergers and acquisitions as regulatory conditions evolve. His optimism about technological advancements was balanced by a thoughtful caution regarding overuse in areas like pharmaceuticals, emphasizing the importance of weighing benefits against risks.The episode was not just a window into Brent's accomplishments but also a reminder of the power of innovation, the importance of adaptability, and the need to continually refine one's craft. For anyone navigating the intersection of technology, business, and leadership, Brent's insights provide both inspiration and actionable guidance. Be sure to tune in to Skin in the Game VC for more conversations with trailblazing leaders and investors shaping the future. Hosted on Acast. See acast.com/privacy for more information.

The past 5 years have brought many changes to the world of aesthetic medicine. We've seen several trends pick up steam in 2024 which we could see continuing to grow in 2025. In this episode we will explain WHAT will grow in popularity, WHY it will, what TREATMENTS fall under these trends, and HOW to find the BEST providers to receive these treatments from!Products Mentioned In This Episode:ZO Pads: https://perfectdoserx.com/products/complexion-renewal-padsTonic: https://perfectdoserx.com/products/tonicBakuchiol: https://perfectdoserx.com/products/bakuchoil-serumPlated: https://perfectdoserx.com/products/plated-skin-science-intense-serum-15-mlTimestamps00:00 Intro00:52 Personal Update02:20 The Last 5 Years of Aesthetic Trends03:52 Trend #1: The Natural Look05:31 Filler Can't Fix Everything07:27 Combining Treatments11:42 Trend #2: Skin Minimalism13:05 Trend #3: Less Lashes14:11 Trend #4: Skin Fitness16:02 Skin Fitness: Plated16:45 Skin Fitness: Bakuchiol18:07 Skin Fitness: Toners - Spray or Pads19:16 Skin Fitness: Vitamin C20:45 In-Office Treatments for Skin Fitness20:55 Monthly Facials21:30 Chemical Peels22:25 Lasers, Microneedling, RF Microneedling24:43 Trend #5: Hair Restoration (Exosomes and Stem Cells)26:40 Alma TED28:01 My #1 Pick for 2025!28:11 Trend #5: Biostimulators30:37 Finding an Experienced InjectorDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

Looking back on the past year and gearing up for 2025,  Robin and Tyler discuss the hottest trends shaping the aesthetics industry. From buzzwords like skinimalism and prejuvenation to the rising influence of GLP-1s for weight loss, they explain how these shifts are redefining the landscape. Hear recommendations for adapting to the ever-changing market dynamics and regulatory landscape while keeping patient care and compliance front and center, including:How to reclaim patient loyalty in the face of Allergan's recent changesIs aesthetics election-proof?Opportunities and potential risks of AI in aestheticsIs e-commerce a game-changer for boosting revenue?How the ballet body trend and Ozempic face are shaping the most sought-after procedures for 2025Robin's top tip for standing out as the industry evolvesHow frictionless spending options improve the patient experienceAre “buy now, pay later” options the new must-have for practices?HostsRobin Ntoh, VP of AestheticsNextechTyler Terry, Director of Sales, MedSpa NextechPresented by Nextech, Aesthetically Speaking delves into the world of aesthetic practices, where art meets science, and innovation transforms beauty.With our team of experts we bring you unparalleled insights gained from years of collaborating with thousands of practices ranging from plastic surgery and dermatology to medical spas. Whether you're a seasoned professional or a budding entrepreneur, this podcast is tailored for you.Each episode is a deep dive into the trends, challenges, and triumphs that shape the aesthetic landscape. We'll explore the latest advancements in technology, share success stories, and provide invaluable perspectives that empower you to make informed decisions.Expect candid conversations with industry leaders, trailblazers and visionaries who are redefining the standards of excellence. From innovative treatments to business strategies, we cover it all.Our mission is to be your go-to resource for staying ahead in this ever-evolving field. So if you're passionate about aesthetics, eager to stay ahead of the curve and determined to elevate your practice, subscribe to the Aesthetically Speaking podcast.Let's embark on this transformative journey together where beauty meets business.About NextechIndustry-leading software for dermatology, medical spas, ophthalmology, orthopedics, and plastic surgery at https://www.nextech.com/ Follow Nextech on Instagram @nextechglow

Host Ryan Dull is joined by Assil Omar, Chief Equity Officer and Vice President, Talent Acquisition of AbbVie. They discuss her unique career journey, the transformation of TA at AbbVie and how the balance between human capital and technology is driving their success.Key Takeaways:(02:40) Assil Omar's background and entry into TA at AbbVie.(08:21) AbbVie's organizational structure and TA function.(12:45) The impact of AbbVie's acquisition of Allergan during COVID.(14:09) Establishing a transformation office to revamp TA.(20:46) Implementing a new operating model and aligning staff globally.(22:36) The importance of hiring manager feedback and measuring success through key TA metrics.(24:54) Balancing technology with the human element in TA.(29:02) Assil's advice for career development in TA.Resources Mentioned:Assil Omar | LinkedIn https://www.linkedin.com/in/assil-omar/AbbVie | LinkedInhttps://www.linkedin.com/company/abbvie/AbbVie | Websitehttps://www.abbvie.comThis episode is brought to you by Sagemark HR.Sagemark HR can help you:✔ Improve your talent practices and make better, more informed people decisions.After 20+ years of experience leading Recruiting and Talent Acquisition across a wide variety of industries, I've seen enough hires (over 100,000 to date) to know that hiring decisions truly can make or break an organization.✔ Identify opportunities to not only improve your talent practices, but also delivering tangible business results.We understand every organization is different, and there's no one-size-fits-all magic solution. So we listen first and identify the gaps and sticking points in your current process before ever recommending a solution.✔ Bridge the gap from “traditional” to modern recruiting, without the painful learning curve.We believe recruiting, talent, and HR technology is a deep well of untapped business potential, and our mission is to help you identify and implement those hiring tools in a way that works for you.If you're interested in learning more, you can reach me at:www.sagemarkhr.com✉ ryan.dull@sagemarkhr.com#Talent #Recruiters #Recruiting #HRTech

The term "facial balancing" is being searched on Google more than ever! Facial balancing is a general term used to describe the personalized process of bringing harmony to one's face through a variety of different treatments - only where it's needed.At Perfect Dose in Scottsdale, we use Botox, biostimulators, lasers, fillers, and more to make you look beautiful and natural.Perkins and Sandel: The "Perfect" Lip: https://www.researchgate.net/profile/Robert-Gotkin/publication/233332464_Six_Steps_to_the_Perfect_Lip/links/553a31ad0cf245bdd76253bf/Six-Steps-to-the-Perfect-Lip.pdf?origin=publication_detail&_tp=eyJjb250ZXh0Ijp7ImZpcnN0UGFnZSI6Il9kaXJlY3QiLCJwYWdlIjoicHVibGljYXRpb25Eb3dubG9hZCIsInByZXZpb3VzUGFnZSI6Il9kaXJlY3QifX0Timestamps00:00 Intro02:00 Recent Celeb Transformation02:42 The Golden Ratio03:17 Different Ethnicity, Different Ratio03:36 Areas Included in Facial Balancing04:01 Perfect Lips for White, Asian, and Black Women07:15 A Perfectly Symmetrical Face?07:39 Chins: Women vs. Men08:45 Ricketts Line10:17 The "Perfect" Lip (My Preferred Method)12:42 How Many Syringes Does It Take?15:12 Injecting Lips!16:32 Facial Balancing Before & After17:04 4 Way That We Age19:14 Low Budget? Do This…19:54 Biostimulators21:30 Skin Tightening23:20 1-Year Facial Balancing Treatment Plan24:55 RecapDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Steven Dell, MD, about his career and the creation of markets in the field of ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 29 1:28  Bausch + Lomb acquires Elios Vision 2:07  ImprimisRx awarded $34.9 million in trademark infringement suit against OSRX 5:00  Study of atropine-based myopia treatment fails to meet primary efficacy endpoint 7:31  Intro of Steven Dell, MD 11:20 You have created markets with new technologies and companies. Can that continue in today's market? 13:28 Dell discusses presbyopia market development. 14:11 You created a questionnaire that you used in your practice, which has become known as the Dell Questionnaire. What do we need to do better in treating our cataract patients? 16:20 What technologies are going to be the most important in the future? 20:24 What has changed in your office environment, i.e., the role of ODs, admin, staff? 22:00 Dell discusses Lindstrom's Integrated Eye Care Delivery Model. 23:08 What advice would you give a younger Steven Dell? 27:16 Neurotech Pharmaceuticals announced that chief commercial officer Scott Hunter died on Dec. 3. 33:06 Give us your feedback 34:43 Thanks 34:51 Steven J. Dell, MD, is a board-certified ophthalmologist in Austin and the Medical Director of Dell Laser Consultants. John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Dell at the time of publication.

The science behind red light therapy suggests that it's one of the best at home treatments to pair with other treatments. This "supercharge" add-on is now available in the form of a convenient, rechargeable, comfortable, and ergonomic face mask tailored to your needs. Acne? You got it. Redness? Yep. Fine lines? That too.Visit our location in Scottsdale or shop online to pickup your face mask today!Use our code for 20% off an Omnilux mask! "PDPODCAST" on https://perfectdoserx.com/Timestamps00:00 Intro 01:28 What is Red Light Therapy?02:17 What Does Red Light Do?04:12 When Should I Use Red Light?07:37 Pairing Red Light and Topicals 08:44 The Red Light Mask I Recommend10:55 How Often to Use Red Light12:15 Neck and Chest12:35 Who Should NOT Get Red Light Therapy13:32 OutroDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this special crossover episode, Eyeluminaries hosts Jim Mazzo and John A. Hovanesian, MD, FACS, are joined live by Susan MacDonald, MD, and Cathleen McCabe, MD, at Eyecelerator 2024 in Chicago, IL. Intro :07 Welcome to the Eyeluminaries podcast 3:14 In this episode 5:02 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 5:11 What started you on this journey to do humanitarian work? 5:30 MacDonald discusses the role of parents in defining of happiness. 10:56 Hovanesian discusses the background of his humanitarian work in Armenia. 11:36 What about the funding of these humanitarian projects? 12:50 What are your stories from doing humanitarian work? 14:11 What advice to do you have for physicians who want to get involved in humanitarian work? 18:55 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 22:23 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 22:50 MacDonald discusses how her humanitarian work began. 23:28 Thank you. 27:05 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 27:51 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 28:42 Visit ACE Global, Cybersight or Operation Sight to get involved. 28:54 Mend the Gap podcast 30:49 Preview of episode 30 32:17 Give us your feedback 32:44 Thanks 33:17 Thoughts 33:27 Visit the ASCRS Foundation to get involved in Operation Sight. 34:20 Thank you for listening! 35:17 Don't forget to like and subscribe to Mend the Gap and Eyeluminaries! 35:39 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on X (formerly Twitter) @Healio_OSN. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

Have you seen these trends online? Just because something has spread through the internet does NOT mean it's good for you or backed by science. Today we break down two trends that have been all over TikTok and other platforms: Topically using beef tallow and face tape! Subscribe to the Dr. Kristen Herzog's channel to get the facts on all emerging beauty trends!Timestamps00:00 Intro00:42 Beef Tallow04:51 Face Tape08:24 Sleep Wrinkles09:46 Redlight Therapy10:16 Botox is Preventative10:58 Dr. Kristen Herzog's Transformation11:23 Recap12:03 OutroDon't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this episode, Jim Mazzo and John A. Hovanesian, MD, FACS, are live from Eyecelerator with Mend the Gap hosts Susan MacDonald, MD, and Cathleen McCabe, MD, discussing their humanitarian work. Welcome to the Eyeluminaries podcast :02 In this episode :31 Intro of Susan MacDonald, MD, and Cathleen McCabe, MD 1:00 What started you on this journey to do humanitarian work? 2:18 MacDonald discusses the role of parents in defining of happiness. 7:47 Hovanesian discusses the background of his humanitarian work in Armenia. 8:24 What about the funding of these humanitarian projects? 9:38 What are your stories from doing humanitarian work? 10:59 What advice to do you have for physicians who want to get involved in humanitarian work? 15:43 Hovanesian discusses the commonalities in MacDonald and McCabe's humanitarian missions. 19:11 McCabe discusses the commonalities in Hovanesian and MacDonald's humanitarian missions. 19:38 MacDonald discusses how her humanitarian work began. 20:16 Thank you. 23:49 MacDonald talks about the ophthalmic industry and their contribution to humanitarian work. 24:39 McCabe discusses ways physicians can get involved in humanitarian work without having to travel overseas. 25:30 Visit ACE Global, Cybersight or Operation Sight to get involved. 25:38 Mend the Gap podcast 27:37 Preview of episode 30 29:05 Give us your feedback 29:25 Thanks 30:05 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Susan MacDonald, MD, is president of Eye Corps and associate clinical professor at Tufts School of Medicine. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, FL. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. MacDonald and McCabe report no relevant financial disclosures.

Fillers and biostimulators have fundamental differences in their makeup and as a result are used for specific purposes. However, at Perfect Dose, Dr. Kristen Herzog often likes to use both to provide a wholistic approach to facial balancing. Listen to this weeks podcast to learn about the different types of fillers, how long they last, comparing them to biostimulators like Sculptra, and designing a treatment plan that uses both tools where needed!Timestamps:00:00 Intro02:46 Natural vs.Fillers04:48 All Procedures Are Optional! 05:16 What AreFillers?07:41 Volume Loss09:17 Areas to Treat10:17 Filler Rheology 13:02 How Long Does Filler Last?19:17 Biostimulators22:45 Using Both25:01 Sculptra for Prevention26:44 The Purpose of These Procedures27:39 Getting a Treatment Plan29:34 Treatment Costs30:32 Choosing a Treatment31:23 Outro

Zachary Silbersher v. Allergan, Inc.

Episode 276 hosts Mike Clague, an Aesthetic Nurse from Melbourne, Australia. Mike joins us in the 24th chapter of our series called 'The Injector Diaries'. These episodes feature in depth conversations, stories and experiences from injectors around the globe. Each injector brings their own unique take on things and we showcase every level of type of injector, from newbies to masters. We'll explore how and why they chose to inject, why they favour using certain products, look under the hoods of their clinics and aim to inspire our injector listeners. 00:00 Introduction and Mike's Background 00:56 Reconnecting After Years 01:25 Early Career and Industry Insights 02:44 Journey with Allergan 04:40 Transition to Aesthetic Nursing 07:50 Mentorship and Training 10:44 Challenges in the Aesthetic Industry 17:52 Regulations and Industry Evolution 22:45 Future of Aesthetic Training 44:37 The Dunning-Kruger Effect 44:58 Clinic Services and Personal Preferences 45:24 Corporate Values and Product Selection 46:12 Consultation Process and Treatment Plans 47:39 Needling and Insulin for Skin Treatment 49:48 Biostimulators 54:39 Filler Brands and Preferences 01:02:07 Future of Aesthetic Treatments 01:10:50 Business Advice for Aesthetic Practitioners 01:14:30 Managing Ischemic Events and Ultrasound Use 01:18:40 Final Thoughts and Reflections JOIN OUR LISTENER WHATSAPP GROUP & SEND US YOUR COMMENTS, SUGGESTIONS OR JUST SAY HI! JOIN OUR PATREON FOR EXCLUSIVE SUBSCRIBER-ONLY PODCASTS, WEEKLY EDUCATIONAL CONTENT & JOIN OUR WHATSAPP COMMUNITY CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST CONTACT US

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news and trends and chat with Tom Mitro about his career and impact in ophthalmology. Welcome to the Eyeluminaries podcast :02 Review of episode 26 :58 FDA grants fast track designation to brepocitinib for noninfectious uveitis 1:42  I. Howard Fine, MD, esteemed ophthalmologist, dies 3:54 First subjects dosed in phase 3 trial of phentolamine ophthalmic solution for presbyopia 5:48 LENZ Therapeutics submits NDA for drops to treat presbyopia 7:57 Intro of Tom Mitro 10:40 Tell us about your journey in ophthalmology 12:38 Tell us about the new dry eye drug from Signal 12. 15:53 How much sensation is on the forehead if the drug is well tolerated? 24:13 What are your thoughts on the current ophthalmology market? 26:01 Tell us a funny story about Jim Mazzo and about John Hovanesian. 28:51 Preview of episode 29 33:25 Give us your feedback 34:34 Thanks 34:50 John A. Hovanesian, MD, FACS, is a faculty member at the UCLA Jules Stein Eye Institute and in private practice at Harvard Eye Associates in Laguna Hills, California. Jim Mazzo is an ophthalmic industry veteran with over 40 years as CEO/chairman of both public and private companies, including Allergan, Avellino Labs, Carl Zeiss, Neurotech Pharmaceuticals and AMO. Additionally, he is an advisor for Bain Capital and CVC Capital Partners and sits on numerous industry boards such as MDMA. Tom Mitro is the president and chief operating officer for Aerie Pharmaceuticals. We'd love to hear from you! Send your comments/questions to eyeluminaries@healio.com. Follow John Hovanesian on X (formerly Twitter) @DrHovanesian. Disclosures: Hovanesian consults widely in the ophthalmic field. Mazzo reports being an advisor for Anivive Lifesciences, Avellino Labs, Bain Capital, CVC Capital and Zeiss; executive chairman of Neurotech, Preceyes BV and TearLab; and sits on the board of Crystilex, Centricity Vision, IanTech, Lensgen and Visus. Healio could not confirm relevant financial disclosures for Mitro at the time of publication.

  In Episode 041 of "Med Spa Marketing Group Chat," hosts Kevin and Bekah are joined by Jason Johnson from Simple Studios for a deep dive into the world of aesthetic photography. Jason shares his journey from a traveling photographer for Allergan to launching Simple Studios, a company dedicated to elevating the quality of before-and-after photos in aesthetic practices. They discuss the importance of high-quality images as a powerful branding and marketing tool in the aesthetic industry. Key takeaways include essential tips on lighting, camera settings, and equipment for achieving consistent, high-quality photos, along with Jason's insights into the latest Simple Studios solutions. RESOURCES: https://www.partnerwithalpha.com/goodies LEARN MORE AND JOIN THE ALPHA COMMUNITY: https://www.partnerwithalpha.com/ FOLLOW ALPHA AESTHETICS PARTNERS: https://www.instagram.com/partnerwithalpha/ https://www.linkedin.com/company/alpha-aesthetics-partners/ CHECK OUT SIMPLE STUDIOS: https://www.simplestudios.pro/    

In this episode of For The Record, Jessica Hunter, CEO & Founder of Hunter Consulting, is in the hot seat to share her proven strategies to drive success in medical aesthetics practices. With over a decade of industry experience, starting with Allergan as a consultant before going at it alone, she's worked with Practices who have yet to open, those with 8 figures in annual revenue, and everything in between. While her approach is rooted in the data and the metrics, she definitely brings in the bigger picture- the mission, vision, values and heart of the Practice. Jessica provides a wealth of actionable insights, guiding you through nearly every aspect of Practice management, but some of our favorites include: Mastering Financial Management: Learn how to track and optimize key performance indicators (KPIs) to improve profitability and ensure sustainable growth. Building a High-Performance Team: Discover effective strategies for hiring, compensating, and managing staff to create a motivated and productive workforce. Crafting a Distinct Brand Identity: Jessica shares the importance of defining your practice's “why” and how it influences every aspect of your brand and patient experience. Lead Generation & Conversion: From targeted marketing to personalized follow-up, uncover how to attract the right patients and turn inquiries into loyal clients. Maximizing Patient Retention: Explore loyalty programs and retention strategies that build long-term relationships and keep patients coming back. Jessica also highlights the importance of aligning your business decisions with your core values, ensuring that every step you take as a Practice Owner is purpose-driven. From leveraging automation in patient communication to creating compelling content that resonates, Jessica offers practical, hands-on advice that is relevant at every stage. Whether you're launching a new practice or scaling an established one, this episode is packed with expert tips to help you lead with confidence and build a thriving, profitable business in the competitive medical aesthetics space. Key Takeaways: Data-Driven Success: How to use financial data to drive strategic growth. Fair Compensation: Balancing staff performance with competitive pay structures. Automation & Patient Experience: Using technology to streamline communication and enhance patient care. Educational Content: How to create valuable, engaging content that builds trust and keeps patients informed. Tune in for this comprehensive masterclass in med spa management and discover how to elevate your practice to the next level! Learn more about Jessica & Hunter Consulting Instagram: ⁠@hunterconsulting_ Website: ⁠hunterconsultingservice.com⁠

Send us a textIn this week's episode of The Yegi Project, Laura Grigoryan, founder of FixMeUpLA Med Spa, is here to tell us about her journey in the aesthetic industry, the challenges of expanding her business, and the importance of social media in marketing. Laura shares insights on building trust with clients, navigating the complexities of aesthetic services, and the significance of continuous education in her field. She emphasizes the need for hard work, passion, and a focused approach to entrepreneurship, inspiring listeners to pursue their dreams in the beauty industry.Connect with Laura & Fix Me Up LA!WebsiteInstagram TikTok FacebookWatch our first episode with Laura: https://youtu.be/S442cCVKxiI Takeaways• Laura is a certified injector with Allergan, known for Botox and Juvederm.• Expanding to a second location can be terrifying but rewarding.• Building trust with clients is crucial when passing responsibilities.• Social media is a powerful tool for marketing and connecting with clients.• Content should be relatable and varied to engage followers.• Filler and Botox can be subtle yet effective when done correctly.• Continuous education is essential in the ever-evolving aesthetic industry.• Marketing strategies should include both social media and word of mouth.• Entrepreneurship requires hard work and dedication to succeed.• Focus on a few key areas to excel rather than spreading too thin.-If you would like to be a guest on a future episode of The Yegi Project, please email info@yegiproject.comThe Yegi Project is available on Apple Podcasts, Spotify, Stitcher and more!https://linktr.ee/theyegiprojectDisclaimer: This podcast or any other The Yegi Project episodes on this platform or other podcast streaming platforms is not legal business or tax advice. I make this content based on my own experience as a business owner and MBA for educational and entertainment purposes only.

Discover the power of Sculptra in this episode, where we dive into the world of bio-stimulators and how they rejuvenate your skin by boosting natural collagen production. Sculptra is a revolutionary treatment that gradually enhances skin texture, firmness, and elasticity over time, giving you long-lasting, natural-looking results. Learn what a bio-stimulator is, why collagen is essential for youthful skin, and how Sculptra injections can be the perfect solution to aging concerns. We also discuss the treatment protocol, costs, and debunk common myths about Sculptra, including concerns about nodules and facelifts. Tune in to get expert advice on achieving radiant, bouncy skin using Sculptra!Whether you're looking to prevent signs of aging or reverse volume loss, this bio-stimulator is for you. Don't miss this episode if you're considering Sculptra or curious about its benefits!Don't forget to follow Dr. Herzog on Instagram @the_perfectdose for more skincare tips!--------------

In this episode of The Fierce Factor, I sit down with Mary Beth Hagen, founder of Titan Aesthetics—a company dedicated to supporting aesthetic injectors and practices across the U.S. Mary Beth is a true pioneer in our industry, bringing decades of experience from roles at Medasis (now Galderma) and Allergan, where she made significant contributions in sales, management, and product development. We dive deep into her unique perspective on aesthetic medicine, touching on the essential qualities that make a great injector and what foundational skills are crucial before entering the field. Mary Beth shares her practical insights into what it takes to thrive in today's corporate-driven medspa landscape, emphasizing the importance of strong compensation plans, staff training, and open communication on growth plans for team members. . This conversation is packed with valuable lessons for anyone looking to hire, train, or become a top-tier injector in their practice. Mary Beth's logical approach and deep understanding of the industry will leave you thinking critically about what it takes to build a thriving, sustainable aesthetic practice. Tune in as we explore what's shaping the future of aesthetics, the guiding principles behind successful practices, and how to bridge the gap between injectors and the corporate practice of medicine. Enjoy this insightful and inspiring chat with my friend and colleague Mary Beth Hagen! Watch this Episode on Youtube Book a Strategy Call with Team KLC Subscribe to our Weekly Newsletter, The Blueprint KLC Consulting Website Kaeli on Instagram Kaeli on LinkedIn

Dr. Kristen delves deep into the transformative benefits of NAD injections. NAD, or nicotinamide adenine dinucleotide, is essential for key functions in the body, including DNA repair, cellular metabolism, and the regulation of circadian rhythm. Through NAD injections, you can significantly boost metabolism by enhancing your body's ability to convert food into energy more efficiently. Not only does this help with weight loss, but it also aids in insulin regulation and cellular health, making NAD injections a powerful tool for those with insulin resistance or metabolic concerns.Dr. Kristen explains how NAD injections improve brain function by clearing brain fog, reducing inflammation, and even offering neuroprotective benefits that may help prevent diseases like Alzheimer's and dementia. NAD also enhances the body's natural energy levels, allowing patients to experience a noticeable energy boost and improved sleep. With better sleep, patients can better manage fatigue and improve overall health.In this episode of The Perfect Dose Podcast, Dr. Kristen Herzog, a board-certified nurse practitioner and national trainer for Allergan and Galderma, explores the world of temple fillers in detail. She begins by discussing the importance of temple filler FDA approval and cadaver lab training, emphasizing the need to understand the complex anatomy of the temples, which includes 10 layers. Dr. Herzog covers how aging affects the temples through bone loss, muscle thinning, and fat deflation, leading to hollowing. She explains how temple fillers, such as Voluma, Restylane, Sculptra, and RHA, can rejuvenate the face by restoring volume while maintaining natural results.Throughout the episode, Dr. Herzog highlights how to identify candidates for temple fillers, the differences in male and female temple aesthetics, and how facial balancing is key to achieving harmony. She also touches on different techniques like needle vs. cannula, combination treatments, and how proper follow-up and maintenance with fillers can prolong results. Finally, Dr. Herzog discusses pricing, choosing the right injector, and the 5 key criteria to monitor for temple hollowing. This comprehensive guide is essential for anyone considering temple filler treatments to enhance their youthful, natural look.Timestamps00:00 Introduction00:32 Why temple filler FDA approval and cadaver lab training are important01:00 How injecting temple filler and analyzing the results is done01:14 Why understanding temple anatomy (10 layers) is important01:46 Why temple fillers make a significant aesthetic difference02:00 How the aging process involves loss of bone, muscle, and fat02:29 How to maintain natural results with temple fillers03:08 How bone loss, skin thinning, and facial fat pad deflation occur with aging04:17 How signs of aging, like lip and temple muscle thinning, are detected05:01 Why male and female temple aesthetics require different treatment approaches06:00 How to identify temple hollowing and determine if you're a candidate for temple filler07:10 Why temple hollowing is more noticeable in some individuals08:27 How facial balancing and harmony are achieved with temple filler09:54 How to monitor for temple hollowing using 5 criteria10:57 How temple hollowing impacts the face and what treatment options are available13:00 Why Voluma is the FDA-approved filler for temple rejuvenation14:37 Why Restylane, Sculptra, and RHA are filler alternatives for temple rejuvenation16:29 How combination treatments with Sculptra and filler can address temple hollowing19:17 How to maintain temple fillers and Sculptra with proper follow-up21:00 How pricing and choosing the right injector affect temple filler outcomes23:00 How techniques like needle vs. cannula are used for temple filler...

In this episode of The Perfect Dose Podcast, Dr. Kristen Herzog, board-certified nurse practitioner and injection specialist, dives into everything you need to know about temple fillers. Dr. Herzog, a national trainer for Allergan and Galderma, explains the anatomy of the temples, signs of aging, and how to determine if you're a candidate for temple fillers. Discover the different treatment options, the importance of facial proportions for both men and women, and why temple fillers are vital for maintaining a youthful, natural look.Timestamps:[00:00] Introduction to temple fillers by Dr. Kristen Herzog, Allergan and Galderma National Trainer[00:32] Temple filler FDA approval and cadaver lab training[01:00] Injecting temple filler and analyzing the results[01:14] Importance of understanding temple anatomy: 10 layers[01:46] Why temple fillers make a significant aesthetic difference[02:00] Understanding the aging process: Loss of bone, muscle, and fat[02:29] How to maintain natural results with temple fillers[03:08] Bone loss, skin thinning, and facial fat pad deflation[04:17] Signs of aging: Lip and temple muscle thinning[05:01] Male vs. female temple aesthetics: Differences in treatment[06:00] How to identify temple hollowing and if you're a candidate for temple filler[07:10] Why temple hollowing is more noticeable in some individuals[08:27] Facial balancing and harmony with temple filler[09:54] 5 criteria to monitor for temple hollowing[10:57] The impact of temple hollowing on the face and treatment options[13:00] Voluma: The FDA-approved filler for temple rejuvenation[14:37] Filler alternatives for temple filler: Restylane, Sculptra, RHA[16:29] Combination treatments with Sculptra and filler for temple hollowing[19:17] Maintenance and follow-up for temple fillers and Sculptra[21:00] Pricing and choosing the right injector for temple fillers[23:00] Techniques for temple filler: Needle vs. cannulaStay tuned for more episodes! For updates and before-and-after photos, follow me on Instagram @ThePerfectDose.LINKS:FIND US AThttps://www.theperfectdose.net/FOLLOW US ON SOCIAL MEDIA: https://www.instagram.com/the_perfectdose/SUBSCRIBE TO OUR YOUTUBE CHANNEL:https://www.youtube.com/@theperfectdoseThe Perfect Dose Podcast is produced by Live Your Truth Media: https://www.liveyourtruth.media/**DISCLAIMER** In this episode, Dr. Kristen misspoke regarding temple filler where the term for female shape is concave and for males is convex.

We hear about the thousands of women suing the breast implant manufacturer Allergan over alleged links with a rare cancer. We have an exclusive interview with a woman who has received a payout from the company after falling sick. Susan Axelby told our reporter Melanie Abbott that she ended up being diagnosed with cancer after having an operation which was supposed to prevent it. Plus, Nuala McGovern was joined by lawyer Sarah Moore to go over details of the case and reveal whether more women in the UK are likely to take action. And Professor Suzanne Turner from Cambridge University discusses her research into this cancer and gives advice to women who have implants, including the fact that the numbers diagnosed are small and it is treatable.Ellen Burstyn has been a star of American stage and screen for 70 years. This week she received the Liberatum Pioneer Award at the Venice Film Festival for her contribution to cinema and the industry, particularly in paving the way for women. She talks to Krupa Padhy about her stories from a lifetime on camera.Head teacher Ruth Perry took her own life in January last year whilst waiting for the publication of an Ofsted report she knew would grade her school as "inadequate". Ruth's sister, Professor Julia Waters, has been campaigning for change in the way Ofsted rates schools ever since. A review was published today into Ofsted's response to Ruth Perry's death, and this week the Government announced changes to the way the school's inspector for England rates schools. Nuala was joined by Professor Waters to give her response.From spongy flesh to wandering wombs, there have been many theories about the inner workings of women across the centuries. In her new book, Immaculate Forms, Professor Helen King talks to Anita Rani about how scientific theories and religious beliefs have shaped our understanding of women's bodies, from Ancient Greece to the present day.This week we speak to not just one Paralympic medallist but two - Team GB triathletes Lauren Steadman and Claire Cashmore, who won bronze and silver in the Para-triathlon category in PTS5. They join Nuala from Paris.Presenter: Krupa Padhy Producer: Annette Wells Editor: Rebecca Myatt

In this episode, we're joined by the legendary Brent Saunders. Brent Saunders is a world-renowned Fortune 500 CEO who has completed more than $300 billion in mergers & acquisitions throughout his career. He is the CEO of Bausch + Lomb, Chairman of Roam, and former CEO of Allergan, which he sold to AbbVie for $83 billion. He is a pioneer in the health & beauty industry and is directly responsible for building some of the biggest consumer brands, including Botox, Claritin, and Coppertone.This is not just a conversation; it's a masterclass in leadership, strategy, and the skills required to steer a global pharmaceutical giant.

We hear about the thousands of women suing the breast implant manufacturer Allergan over alleged links with a rare cancer. We have an exclusive interview with a woman who has received a pay-out from the company after falling sick. Susan Axelby tells our reporter Melanie Abbott that she ended up being diagnosed with cancer after having an operation which was supposed to prevent it. Plus, Nuala McGovern is joined by lawyer Sarah Moore to go over details of the case and reveal whether more women in the UK are likely to take action. And Professor Suzanne Moore from Cambridge University will discuss her research into this cancer and give advice to women who have implants, including the fact that the numbers diagnosed are small and it is treatable.Actor and producer Gemma Arterton returns to our screens this week for the second season of Funny Woman, which tells the story of Sophie, a comedian trying to forge a path for women's voices in the male-dominated world of 1960s comedy. Gemma joins Nuala to tell her about the series and her own passion for getting women's voices heard.Giuseppe and his Nonna, Marianna, have been making social media content together since 2021, sharing videos of them making food inspired by Nonna's Italian home cooking, but vegan. Giuseppe and Marianna join Nuala to discuss their relationship, how Nonna found social media fame in her 80s, and their first cookbook Cooking with Nonna. Presenter: Nuala McGovern Producer: Maryam Maruf Editor: Deiniol Buxton Studio Manager: Gayl Gordon

Maryland Democrats were on the mainstage at this week's Democratic National Convention with speeches from Governor Wes Moore, Congressman Jamie Raskin and Prince George's County Executive and Senate candidate Angela Alsobrooks. Josh Kurtz, founding editor of Maryland Matters joins Midday to reflect on Maryland's impact in Chicago. Then, Baltimore City recently settled for $152 million with Cardinal Health for their role in the opioid crisis. This large amount follows $45 million settlements with CVS and Allergan earlier this year. WYPR health reporter Scott Maucione joins Midday to explain the details of the settlement and how the funds will be used.Email us at midday@wypr.org, tweet us: @MiddayWYPR, or call us at 410-662-8780.

Jack Quinn: Head, State Government Affairs for Regeneron Pharmaceuticals Jack Quinn leads Regeneron Pharmaceutical's state policy, advocacy, regulatory, and political activity across all 50 states. Born-and-raised in Buffalo, NY, Jack attended Siena College and SUNY Buffalo Law School.  After being admitted to the New York Bar, Quinn served as a prosecutor for the Erie County District Attorneys Office. Elected to the New York State Assembly in 2004.  Jack served six years (2005-2010) in the legislature representing the 146th Assembly District (Erie County).  A member of the Republican Party, Quinn served on the Assembly Judiciary, Higher Education, Banks, Transportation and Ethics Committees. Following his six-year tenure in the Assembly, Jack has spent the last 14 years lobbying across 35+ states for several pharmaceutical manufacturers (Allergan, Vertex, and Sanofi) as well as ExxonMobil.  In his two prior roles, Quinn led State Government Relations teams for Alexion Pharmaceuticals and Regence BlueCross BlueShield. In addition to his role with Regeneron, Jack has also spent the last six years serving as a Northeast Charter School Network (NESCN) board member.  NESCN is a non-profit organization that advocates for pro-charter school legislative policies on behalf of over 150 school across New York and Connecticut.  Jack and his family live in Manhattan.